Coya Therapeutics, Inc. — Form 8-K
Filed October 5, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 8/100
What the filing says
Coya Therapeutics filed a Form 8-K on October 5, 2026, reporting Item 8.01 (Other Events). The filing does not disclose the substantive content of the event in the provided document excerpt—only the filing metadata, XBRL exhibits, and company contact information are shown. No counterparties, dollar amounts, dates of material transactions, or specific business developments are stated in this excerpt.
Why this rating
Cannot assess significance without disclosed event details. Generic Item 8.01 filing is routine unless substance is material; company scale $89.4M makes even modest events meaningful, but absence of specifics prevents scoring higher.
Extracted items
See more from October 5, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.